Alejandra Sánchez

840 total citations
27 papers, 385 citations indexed

About

Alejandra Sánchez is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Alejandra Sánchez has authored 27 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Rheumatology and 5 papers in Hematology. Recurrent topics in Alejandra Sánchez's work include Spondyloarthritis Studies and Treatments (9 papers), T-cell and B-cell Immunology (9 papers) and Immune Cell Function and Interaction (8 papers). Alejandra Sánchez is often cited by papers focused on Spondyloarthritis Studies and Treatments (9 papers), T-cell and B-cell Immunology (9 papers) and Immune Cell Function and Interaction (8 papers). Alejandra Sánchez collaborates with scholars based in Spain, Portugal and United States. Alejandra Sánchez's co-authors include José María Rojo, María José Feito, Juan Mulero, Eduardo Collantes‐Estévez, Pilàr Portolés, Javier Almorox, Chiquinquirá Hontoria, Antonio Saá-Requejo, Gabriel Criado and Magdalena Szczypiorska and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Alejandra Sánchez

27 papers receiving 377 citations

Peers

Countries citing papers authored by Alejandra Sánchez

Since Specialization

Citations

This map shows the geographic impact of Alejandra Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Sánchez more than expected).

Fields of papers citing papers by Alejandra Sánchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Sánchez. The network helps show where Alejandra Sánchez may publish in the future.

Co-authorship network of co-authors of Alejandra Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Sánchez. A scholar is included among the top collaborators of Alejandra Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Sánchez. Alejandra Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Kissy Guevara‐Hoyer, (unknown), Alejandra Sánchez, E. D. Carosella, Alberto Ocaña, Silvia Sánchez‐Ramón	4
2	Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset. 2019 ·PubMed ·(unknown), Magdalena Szczypiorska, (unknown), José Luís López-Campos, (unknown), Jesús Sanz, Cruz Fernández-Espartero, Teresa Clavaguera, (unknown), Marta Artieda, Diego Tejedor, Antonio Martínez, Juan Mulero, (unknown), José Luís Andreu, Alejandra Sánchez	10
3	A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis 2016 ·PLoS ONE ·José Ramón Vidal-Castiñeira, Antonio López‐Vázquez, Roberto Díaz‐Peña, (unknown), Pablo Martínez‐Camblor, Eliécer Coto, Pablo Coto‐Segura, Jácome Bruges‐Armas, José Pinto, Francisco J. Blanco, Alejandra Sánchez, Juan Mulero, Rubén Queiró, Carlos López‐Larrea	17
4	SAT0360 Etanar – A Etanercept Biosimilar is as Effective as Adalimumab and Infliximab in a Cohort of Real-Life of Patients with Rheumatoid Arthritis 2015 ·Annals of the Rheumatic Diseases ·P. Santos-Moreno, (unknown), L. Villarreal, (unknown), Juan Manuel Bello-Gualtero, (unknown), (unknown), Alejandra Sánchez, (unknown), (unknown), Michele Hilton Boon	4
5	Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis 2014 ·Clinical & Experimental Immunology ·Roberto Díaz‐Peña, José Ramón Vidal-Castiñeira, Juan Mulero, Alejandra Sánchez, Rubén Queiró, Carlos López‐Larrea	18
6	Candidate’s single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis 2013 ·Rheumatology International ·(unknown), Alejandra Sánchez, Alejandro Escudero‐Contreras, (unknown), Magdalena Szczypiorska, Pilar Font, Antonio Martínez, Diego Tejedor, Marta Artieda, Juan Mulero, Anca Dana Buzoianu, Eduardo Collantes‐Estévez	13
7	Real-time detection of the chemokine CXCL12 in urine samples by surface plasmon resonance 2013 ·Talanta ·Beatriz Vega, A. Calle, Alejandra Sánchez, Laura M. Lechuga, Ana M. Ortiz, G. Armelles, José Miguel Rodríguez‐Frade, Mario Mellado	23
8	A high density SNP genotyping approach within the 19q13 chromosome region identifies an association of a CNOT3 polymorphism with ankylosing spondylitis 2012 ·Annals of the Rheumatic Diseases ·Roberto Díaz‐Peña, Ana M. Aransay, Beatriz Suárez-Álvarez, Jácome Bruges‐Armas, Naiara Rodríguez‐Ezpeleta, María Regueiro, Fernando Pimentel‐Santos, Juan Mulero, Alejandra Sánchez, Eduardo Collantes‐Estévez, Rubén Queiró, Javier Ballina, Helena Alves, Carlos López‐Larrea	12
9	Genetic polymorphisms inside and outside the MHC improve prediction of AS radiographic severity in addition to clinical variables 2012 ·Lara D. Veeken ·(unknown), Magdalena Szczypiorska, Alejandra Sánchez, Jesús Sanz, (unknown), Jordi Gratacós, Pedro Zarco, Eduardo Collantes‐Estévez, (unknown), (unknown), Marta Artieda, Juan Mulero	13
10	Both Baseline Clinical Factors and Genetic Polymorphisms Influence the Development of Severe Functional Status in Ankylosing Spondylitis 2012 ·PLoS ONE ·(unknown), (unknown), Alejandra Sánchez, Magdalena Szczypiorska, Jesús Sanz, Eduardo Cuende, Eduardo Collantes‐Estévez, Antonio Martínez, Diego Tejedor, Marta Artieda, Anca Dana Buzoianu, Juan Mulero	8
11	ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population 2011 ·Lara D. Veeken ·Magdalena Szczypiorska, Alejandra Sánchez, (unknown), David Arteta, Jesús Sanz, (unknown), Pilar Fernández-García, Eduardo Collantes‐Estévez, Antonio Martínez, Diego Tejedor, Marta Artieda, Juan Mulero	42
12	Fine mapping of a major histocompatibility complex in ankylosing spondylitis: Association of the HLA–DPA1 and HLA–DPB1 regions 2011 ·Arthritis & Rheumatism ·Roberto Díaz‐Peña, Ana M. Aransay, Jácome Bruges‐Armas, Antonio López‐Vázquez, Naiara Rodríguez‐Ezpeleta, Iñaki Mendibil, Alejandra Sánchez, Juan Carlos Torre‐Alonso, (unknown), Juan Mulero, Eduardo Collantes‐Estévez, Carlos López‐Larrea	13
13	Association of the Intergenic Single-Nucleotide Polymorphism rs10865331 (2p15) with Ankylosing Spondylitis in a Spanish Population 2010 ·The Journal of Rheumatology ·Alejandra Sánchez, Magdalena Szczypiorska, Xavier Juanola, (unknown), Jordi Gratacós, Pedro Zarco, Eduardo Collantes‐Estévez, Marta Artieda, Antonio Martínez, Diego Tejedor, Juan Mulero	9
14	Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: Binding to M type 18 strains is independent of Emm or Enn proteins 2007 ·Molecular Immunology ·María José Feito, Alejandra Sánchez, (unknown), David Pérez-Caballero, Santiago Rodrı́guez de Córdoba, Sebastián Albertí, José María Rojo	14
15	CD46‐mediated costimulation induces a Th1‐biased response and enhances early TCR/CD3 signaling in human CD4⁺ T lymphocytes 2004 ·European Journal of Immunology ·Alejandra Sánchez, María José Feito, José María Rojo	41
16	The Chemical Composition of Precipitation in Madrid 2003 ·Water Air & Soil Pollution ·Chiquinquirá Hontoria, Antonio Saá-Requejo, Javier Almorox, (unknown), Alejandra Sánchez, (unknown)	53
17	Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways 2002 ·European Journal of Immunology ·María José Feito, Rosanna Vaschetto, Gabriel Criado, Alejandra Sánchez, Annalisa Chiocchetti, (unknown), Umberto Dianzani, Pilàr Portolés, José María Rojo	34
18	Variability of invariant mouse CD3ε chains detected by anti-CD3 antibodies 2000 ·European Journal of Immunology ·Gabriel Criado, María José Feito, Gloria Ojeda, Alejandra Sánchez, Charles A. Janeway, Pilàr Portolés, José María Rojo	8
19	A study of the chick thymus microenvironment during development: Analysis by monoclonal antibodies against thymic epithelium 1993 ·The Anatomical Record ·P. de Paz, Alejandra Sánchez, (unknown), (unknown), C.A. Chamorro	4
20	A monoclonal antibody that detects a specific human neutrophil antigen involved in phorbol myristate acetate- and formyl-methionyl-leucyl-phenylalanine-triggered respiratory burst 1992 ·The Journal of Immunology ·Pedro Miguel Lacal, Isabel Barasoaı́n, Alejandra Sánchez, Javier García‐Sancho, Ignacio Flores, Faustino Mollinedo	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact